Corcept Therapeutics (CORT) PT Lowered to $50 at Truist Securities
Tweet Send to a Friend
(Updated - December 31, 2025 12:36 PM EST)
Truist Securities analyst Joon Lee lowered the price target on Corcept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Joon Lee lowered the price target on Corcept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
